Researchers received a $7.6 million grant to investigate PhytoSERM, a supplement that may treat menopausal symptoms and lower Alzheimer’s disease risk.

The FDA has granted a Fast Track Designation to ofra-vec (ofranergene obadenovec; VB-111) in combination with paclitaxel as a potential treatment for patients with platinum-resistant ovarian cancer.

Richard Carmona, MD, MPH, distinguished laureate professor of public health at the Mel and Enid Zuckerman College of Public Health, wrote an opinion column about COVID-19 vaccine boosters.

University of Arizona Health Sciences faculty offer encouragement and advice for new graduates beginning the next phase in their professional lives.

Researchers from the University of Arizona Health Sciences co-author an article describing their study that appears to be a promising treatment option for pediatric and young adult patients undergoing haploidentical bone marrow transplantation.

New Mexico’s wildfire season is here early and we know from the past two years that wildfires only add to the threat of the coronavirus pandemic. Paloma Beamer, PhD, a professor at the Mel and Enid Zuckerman College of Public Health, is quoted.

Pinterest is packed with misleading cancer-related nutrition information according to a new analysis that included researchers from the UArizona Cancer Center.

Valley fever, contracted by inhaling the Coccidioides fungus that flourishes in Southwestern soils, is spiking on its home turf and migrating to new territories. John Galgiani, MD, director of the Valley Fever Center for Excellence in the University of Arizona College of Medicine – Tucson, is quoted. Related content.

Throughout his career spent studying opioids, Todd Vanderah, PhD, has been determined to find a way to manage pain without increasing the risk of addiction.